Lisa Marie Fröhlich

Enhanced expression of p21 promotes sensitivity of melanoma cells towards targeted therapies

B. Schittek, T. Sinnberg, Lisa Marie Fröhlich, 2022, Experimental dermatology.

Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition

C. Garbe, B. Schittek, B. Sauer, 2020, Cell Death & Disease.

PARP Inhibitors Effectively Reduce MAPK Inhibitor Resistant Melanoma Cell Growth and Synergize with MAPK Inhibitors through a Synthetic Lethal Interaction In Vitro and In Vivo

B. Schittek, T. Sinnberg, H. Niessner, 2023, Cancer research communications.